, May 12, 2014
/PRNewswire-iReach/ -- Clinilabs, a contract research organization that provides early-phase and specialty clinical drug development services to industry, announced today that they have initiated an Asian Bridging study to evaluate the safety, tolerability and pharmacokinetics of an investigational medication for the treatment of female infertility. The study will be conducted at Clinilabs' New York City
Photo - http://photos.prnewswire.com/prnh/20140509/86291
Clinilabs has been conducting studies of this nature since 2012 and is recognized as an industry leader in Asian Bridging. These studies are a critical aspect of the drug development process because people of Asian descent can metabolize drugs differently than others. Therefore, Asian regulatory authorities may require absorption, distribution, metabolism, and excretion (ADME) data in Asian subjects before a drug is approved for marketing.
Clinilabs' Phase I units are located in regions that are home to the largest Asian population in the US who meet standard criteria for bridging studies, making them the world's leading destinations for single- or multi-center Asian Bridging trials. When asked about the potential difficulties in recruiting Japanese volunteers for these complex studies, Manager of Recruitment and Outreach, Carrie Sorkin states "With our extensive database of over 70,000 volunteers, we can easily meet recruitment criteria for any study, particularly Japanese Bridging." With a multilingual staff and Phase I units providing cultural accommodations, Clinilabs holds the best volunteer retention of any study center due to its volunteer care and commitment.
Clinilabs is currently enrolling healthy females, of Japanese descent, between the ages of 21 and 35 who have a history of normal menstrual cycles. Those who qualify may be eligible to receive up to $6,000 in compensation for time and travel. Japanese women in the New York City Metro area who would like to participate can contact our call center at 212-994-4567 to prequalify. Additional information may also be found by visiting www.clinilabs.com/japanese.
Japanese version available upon request.*
Media Contact:Hannah DAoust, Clinilabs, 646-215-6480, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com